DK278178A - Sulfamoylarylketoner deres fremstilling og anvendelse - Google Patents

Sulfamoylarylketoner deres fremstilling og anvendelse

Info

Publication number
DK278178A
DK278178A DK278178A DK278178A DK278178A DK 278178 A DK278178 A DK 278178A DK 278178 A DK278178 A DK 278178A DK 278178 A DK278178 A DK 278178A DK 278178 A DK278178 A DK 278178A
Authority
DK
Denmark
Prior art keywords
rylketones
sulfamoyl
preparation
sulfamoyl rylketones
Prior art date
Application number
DK278178A
Other languages
Danish (da)
English (en)
Inventor
H J Lang
J Musil
R Muschaweck
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK278178A publication Critical patent/DK278178A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)
DK278178A 1977-06-21 1978-06-20 Sulfamoylarylketoner deres fremstilling og anvendelse DK278178A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772727802 DE2727802A1 (de) 1977-06-21 1977-06-21 Sulfamoyl-arylketone und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DK278178A true DK278178A (da) 1978-12-22

Family

ID=6011950

Family Applications (1)

Application Number Title Priority Date Filing Date
DK278178A DK278178A (da) 1977-06-21 1978-06-20 Sulfamoylarylketoner deres fremstilling og anvendelse

Country Status (9)

Country Link
US (1) US4156732A (de)
EP (1) EP0000128A1 (de)
JP (1) JPS549259A (de)
AU (1) AU3728978A (de)
DE (1) DE2727802A1 (de)
DK (1) DK278178A (de)
IL (1) IL54945A0 (de)
IT (1) IT1096492B (de)
ZA (1) ZA783511B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5835653U (ja) * 1981-09-03 1983-03-08 三國工業株式会社 始動装置のワツクス加熱調整回路
JPS5848963U (ja) * 1981-09-28 1983-04-02 本田技研工業株式会社 電熱式オ−トチヨ−ク付気化器
JPS58186152U (ja) * 1982-06-07 1983-12-10 本田技研工業株式会社 多連式気化器におけるア−ス装置
DE3317884A1 (de) * 1983-05-17 1984-11-22 Hoechst Ag, 6230 Frankfurt 5-(4-chlor-3-sulfamoylbenzoyl)-2,3-dihydro-2-benzofurancarbonsaeuren und verfahren zu ihrer herstellung
US4745222A (en) * 1983-05-25 1988-05-17 Merrell Dow Pharmaceuticals Inc. Novel aryloxycycloalkanolaminoalkylene aryl ketones
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
JP2004517804A (ja) * 2000-06-28 2004-06-17 メルク・アンド・カンパニー・インコーポレーテッド 心臓血管病の治療法
EP1883405A4 (de) 2005-05-09 2010-01-27 Takeda Pharmaceuticals North A Verfahren zur behandlung von nephrolithiase
CA2617248C (en) * 2005-08-03 2015-09-29 Tap Pharmaceutical Products, Inc. Methods for treating hypertension
US20090124623A1 (en) * 2006-11-13 2009-05-14 Christopher Lademacher Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors
WO2008064015A1 (en) * 2006-11-13 2008-05-29 Takeda Pharmaceuticals North America Methods for preserving renal function using xanthine oxidoreductase inhibitors
MX2009007680A (es) * 2007-01-19 2011-08-03 Takeda Pharmaceuticals North America Inc Metodos para prevenir o reducir el numero de expansiones graduales de gota utilizando inhibidores de oxidoreductasa de xantina y agentes anti-inflamatorios.
ES2524259T3 (es) * 2008-03-24 2014-12-04 Novartis Ag Inhibidores de metaloproteinasa de matriz a base de arilsulfonamida
US20100311756A1 (en) * 2009-01-22 2010-12-09 Takeda Pharmaceuticals North America, Inc. Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof
AU2011299153B2 (en) 2010-09-10 2014-10-30 Takeda Pharmaceuticals U.S.A., Inc. Methods for concomitant treatment of theophylline and febuxostat
CN106008421A (zh) * 2016-06-12 2016-10-12 南方医科大学 一种能促进尿酸排泄的人体尿酸盐转运体-1抑制剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL108331C (de) *
GB1521932A (en) * 1976-03-08 1978-08-16 Labaz Sulphonamide derivatives and process for preparing the same

Also Published As

Publication number Publication date
ZA783511B (en) 1979-06-27
EP0000128A1 (de) 1979-01-10
DE2727802A1 (de) 1979-04-19
IL54945A0 (en) 1978-08-31
AU3728978A (en) 1980-01-03
IT1096492B (it) 1985-08-26
IT7824695A0 (it) 1978-06-19
JPS549259A (en) 1979-01-24
US4156732A (en) 1979-05-29

Similar Documents

Publication Publication Date Title
DK377678A (da) 3,4,5-trihydroxypiperidinderivater deres fremstilling og anvendelse
DK242578A (da) Tetrahydrofuranderivater deres fremstilling og anvendelse
DK168579A (da) Corticoid-21-halogen-17-alkylcarbonater deres fremstilling og anvendelse
NO780312L (no) Hydrofile kopolymerer og deres fremstilling
DK279578A (da) Sulfonamidderivater og deres anvendelse som herbicider
DK543879A (da) Monoazopigmentblandinger deres fremstilling og anvendelse
DK278178A (da) Sulfamoylarylketoner deres fremstilling og anvendelse
DK156579A (da) Oximino-triazolyl-ethaner deres fremstilling og anvendelse som fungicider
DK547378A (da) 1-n-4,6-di-o(aminoglycosyl-)-1,3-dimino-cyclitol-derivater deres fremstilling og anvendelse
DK539979A (da) Quinazolinonderivater samt deres fremstilling og anvndelse
DK291478A (da) N!-phenyl-n-methylurinstofderivater deres fremstilling og anvendelse
DK108078A (da) Benzodiazepinderivater deres fremstilling og anvendelse
DK307978A (da) Pigmentpraeparater deres fremstilling og anvendelse
DK474678A (da) Halogenvinyl-gamma-butyrolactoner samt deres fremstilling og anvendelse
DK155280A (da) Distyrylbenzener deres fremstilling og anvendelse
DK155380A (da) Distyrylbiphenyler deres fremstilling og anvendelse
DK286480A (da) Oxinethere deres fremstilling og anvendelse
DK301680A (da) N-carboxylerede carbamater deres fremstilling og anvendelse
DK319478A (da) Angiotensinpeptider og deres fremstilling
DK318278A (da) Beta-lactamforbindelser samt deres femstilling og anvendelse
DK254077A (da) Benzylcyanocetaler deres fremstilling og anvendelse
DK326980A (da) 25-halogen-cholest-5-en-3beta,22-dioler og estere deraf deres fremstilling og anvendelse
DK299578A (da) Bleomyciner samt deres fremstilling og anvendelse
DK131379A (da) Steroid-spiro-oxazolderivater deres fremstilling og anvendelse
DK24280A (da) Spiro-quinolylhydantoiner fremgangsmaade til deres fremstilling og deres anvendelse